Dr James Evans, one of SMTL's health services researchers, has recently had a paper published in Applied Health Economics and Health Policy ("Thopaz+ Portable Digital System for Managing Chest Drains: A NICE Medical Technology Guidance", Evans, J.M., Ray, A., Dale, M. et al. Appl Health Econ Health Policy (2019)).

The work,  undertaken when James was working for CEDAR, assessed the  clinical evidence for Thopaz+, and  showed shorter drainage times and length of hospital stay, lower rates of chest drain re-insertion and higher rates of patient satisfaction when used in patients following pulmonary resection compared to conventional chest drainage. One comparative study of the use of Thopaz+ in patients with spontaneous pneumothorax was identified and showed shorter drainage times and length of hospital stay compared to conventional drainage.

The authors concluded that the use of Thopaz+ in patients following pulmonary resection and patients with pneumothorax led to cost savings compared to conventional drainage. The main driver for cost savings was a reduction in length of hospital stay.


Since the first British Standards for compression hosiery were published in the 1980's, the use of compression garments to treat various clinical complications has changed significantly.  Performance requirements and test parameters which seemed appropriate 33 years ago  are now causing confusion for users of the products and operational difficulties for test houses and manufacturers.

To address these issues a new standard - BS 661210:2018 - has recently been published.  BS 661210 is a revision and merger of three previous standards (BS 6612:1985, BS 7563:1999 and BS 7672:1993) for graduated compression hosiery, anti-embolism hosiery and graduated support hosiery. The BSI Panel took the opportunity of the revision to address inconsistencies in the previous standards, clarifying various test parameters and technical issues,  and producing a  single consistent test method to test both medical and non-medical compression garments.

As well as specifying the test method, the Standard sets out performance requirements  for the compression and stiffness of these devices, and these have been updated to reflect current clinical UK guidance .  A new  informative Rationale Annex (Annex C) has been included to explain the thinking behind most of the major changes in the Standard, and another new Annex (Annex D) explains the variety of classes and compression profiles used in the UK that are referenced in various standards and clinical guidance documents.

Peter Phillips (Director of SMTL) is chair of BSI committee CH/205/1, under which the Panel operated, and Dr Gavin Hughes (Deputy Director, SMTL) acted as Editor of the standard.

Pete Phillips and James Evans were  invited to the 9th RCSEd All Wales Medical & Dental Student Surgical Research symposium at Margam Orangery in October 2018 to judge poster and oral presentations and to present the SMTL award for best science paper.  

The winner was Jeremy Chan and his colleagues Ren Chet Teh, Jacky Cheng, Pushpinder Sidhu for their poster on "Inappropriate blood tests in cardiac surgery intensive care".

Jeremy and his colleagues demonstrated that £75,000 could be saved in a single CSICU by eliminating unnecessary blood tests, and reducing the risk of anaemia due to iatrogenic blood loss. The poster exhibited three clear aims, a methodology which could be replicated, simple reporting of the results, good discussion of their limitations and a concise set of conclusions.

The photo shows Pete Phillips, Director of SMTL, handing Jeremy his award trophy

A few weeks ago, SMTL hosted  UKAS, the United Kingdom Accreditation Service, for our annual independent inspection.

Over a period of two days, two inspectors asked SMTL staff to undertake a variety of tests, observing whether they complied with our QMS (Quality Management System) and adhered to the requirements of ISO 17025, the international standard for testing labs.

The two inspectors covered the fields of physical and biological testing, inspecting a variety of paperwork, including testing projects, training records, calibration certificates and inter-laboratory proficiency tests.

The inspection went well, with the inspectors complimenting SMTL on their management and control of testing.  They recommended that SMTL maintain their accreditation status.   

SMTL's latest UKAS accreditation schedule is available for download from  the UKAS website.

All of us at SMTL are delighted to hear that Dr Steve Thomas,  Director of the Surgical Materials Testing Laboratory (SMTL) from 1989 until 2005, has been awarded an OBE (Officer of the Order of the British Empire) for services to the NHS in the 2018 Queen\'s Birthday Honours.

Steve studied pharmacy at Cardiff University followed by a PhD on gluteraldehyde.   His initial post in the NHS was as QC Pharmacist for Mid Glamorgan Health Authority, where he started in 1970. As the laboratory grew Steve developed an interest in wound dressings and medical devices, and his expertise was recognised by the Welsh Office who appointed him as the Surgical Dressings QA Pharmacist for Wales.  When the laboratory moved from East Glamorgan Hospital to Bridgend General Hospital in 1989, Steve became the first Director of SMTL.

Steve is recognised internationally as a world expert on woundcare products, establishing the first NHS medical device and dressings testing lab in the UK for the Wesh Office. He has written over 150 papers and articles on surgical dressings, bandages and maggots and set up the first European sterile production centre for maggots used for wound debridement, reintroducing maggot debridement therapy to Europe, and turned this into a commercial venture which was spun off by the NHS as Zoobiotics in 2005 when Steve left the NHS.

As Director of the Welsh NHS Surgical Materials Testing Laboratory (SMTL) he developed it into an internationally recognised leading centre for its work in on medical devices and surgical dressings. Steve was editorial advisor to the British National Formulary (BNF), founder member of the editorial board of the Journal of Wound Care, Senior editorial advisor to World Wide Wounds and editor of the Formulary of Wound Management Products. He developed the first performance-based test methods for modern wound- care products, which were adopted by the British Pharmacopoeia and the European Standards organisation CEN, as well as the test method used for over 30 years for bandages.

He was long term member of Committee L of the British Pharmacopoeia, editorial advisor to MIMs as well as a member of multiple BSI and CEN standards committees. He was a twice winner of the Nicholas Award (Guild of Hospital Pharmacists), and in 2001 gained the Queen’s Award for Innovation for the LarvE project. In 2002 he was joint winner of the William Hunting Award (British Veterinary Association), again for his work with maggot therapy.

After leaving Zoobiotics in 2007, he set up a medical device consultancy, Medetec, which continues to provide expert advice and consultancy to the dressings industry and the NHS in Wales. He published a number of recent papers on the effects of humidity on dressing performance and measurement of sub-garment pressure, which lead to the development of an apparatus used in the Welsh NHS as part of their evidence-based procurement programme, and which is under consideration for adoption as a UK standard.

Steve continues to be relied on for advice to European Working Groups on dressings test methods, for indusry as an expert witness in legal cases, and has recently been commissioned by NHS Wales to produce Health Technology Assessments. He is the author of several patents related to dressings and maggot production and distribution. His 2010 book on “Surgical Dressings & Wound Management” is considered internationally to be the standard reference on dressings.

More Articles...

Joomla Template: by JoomlaShack